TY - JOUR T1 - H2020 funding for respiratory research: scaling up for the prevention and treatment of lung diseases JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.01417-2019 VL - 54 IS - 3 SP - 1901417 AU - Constantine I. Vardavas AU - Christina N. Kyriakos AU - Esteve Fernández AU - Panagiotis Bamidis AU - Kamran Siddiqi AU - Niels H. Chavannes AU - R.M.J.J. van der Kleij AU - Gary Parker AU - Cornel Radu-Loghin AU - Brian Ward AU - Karim Berkouk Y1 - 2019/09/01 UR - http://erj.ersjournals.com/content/54/3/1901417.abstract N2 - Respiratory diseases represent a significant public health challenge, in terms of disability and premature mortality, and also direct healthcare costs, drugs prescribed and the indirect costs related to lost productivity [1].This European Lung Corner article summarises five key messages for future research and practice in preventing and treating lung diseases based on outcomes and perspectives from five Horizon 2020 projects http://bit.ly/2YCJV5NEuropean Respiratory Society (ERS) and the European Network for Smoking and Tobacco Prevention (ENSP) for organising the European Parliament event on 18th October 2018: “H2020 funding for tobacco control: scaling up for the prevention of lung diseases in the EU”; MEP Gilles Pargneaux for hosting; Tamsin Rose for moderating; Marine Faure, Valérie Vaccaro and Céline Genton for organising. The International Tobacco Control Policy Evaluation Project (the ITC Project) for their role in the EUREST-PLUS Project. Consortium Members of the five Horizon2020 projects: EUREST-PLUS, TackSHS, TB & Tobacco, FRESH AIR, and SmokeFreeBrain.The views expressed in this publication are the sole responsibility of the authors and do not necessarily reflect the official position of the European Commission. Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use that might be made of the information contained in this article. ER -